Distinguishing Benign from Malignant Pancreatic and Periampullary Lesions Using Combined Use of (1)H-NMR Spectroscopy and Gas Chromatography–Mass Spectrometry

Previous work demonstrated that serum metabolomics can distinguish pancreatic cancer from benign disease. However, in the clinic, non-pancreatic periampullary cancers are difficult to distinguish from pancreatic cancer. Therefore, to test the clinical utility of this technology, we determined whethe...

Descripción completa

Detalles Bibliográficos
Autores principales: McConnell, Yarrow J., Farshidfar, Farshad, Weljie, Aalim M., Kopciuk, Karen A., Dixon, Elijah, Ball, Chad G., Sutherland, Francis R., Vogel, Hans J., Bathe, Oliver F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372206/
https://www.ncbi.nlm.nih.gov/pubmed/28098776
http://dx.doi.org/10.3390/metabo7010003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372206/
https://www.ncbi.nlm.nih.gov/pubmed/28098776
http://dx.doi.org/10.3390/metabo7010003

Ejemplares similares